Background/Aims Liver cirrhosis is an important cause of morbidity and mortality globally. Every episode of decompensation and hospitalization reduces survival. We studied the clinical profile and long-term outcomes comparing alcohol-related cirrhosis (ALC) and non-ALC.
Methods Cirrhosis patients at index hospitalisation (from January 2010 to June 2017), with ≥1 year follow-up were included.
Result s: Five thousand and one hundred thirty-eight cirrhosis patients (age, 49.8±14.6 years; male, 79.5%; alcohol, 39.5%; Child-A:B:C, 11.7%:41.6%:46.8%) from their index hospitalization were analysed. The median time from diagnosis of cirrhosis to index hospitalization was 2 years (0.2–10). One thousand and seven hundred seven patients (33.2%) died within a year; 1,248 (24.3%) during index hospitalization. 59.5% (2,316/3,890) of the survivors, required at least one readmission, with additional mortality of 19.8% (459/2,316). ALC compared to non-ALC were more often (P<0.001) male (97.7% vs. 67.7%), younger (40–50 group, 36.2% vs. 20.2%; P<0.001) with higher liver related complications at baseline, (P<0.001 for each), sepsis: 20.3% vs. 14.9%; ascites: 82.2% vs. 65.9%; spontaneous bacterial peritonitis: 21.8% vs. 15.7%; hepatic encephalopathy: 41.0% vs. 25.0%; acute variceal bleeding: 32.0% vs. 23.7%; and acute kidney injury 30.5% vs. 19.6%. ALC patients had higher Child-Pugh (10.6±2.0 vs. 9.0±2.3), model for end-stage liver-disease scores (21.49±8.47 vs. 16.85±7.79), and higher mortality (42.3% vs. 27.3%, P<0.001) compared to non-ALC.
Conclusions One-third of cirrhosis patients die in index hospitalization. 60% of the survivors require at least one rehospitalization within a year. ALC patients present with higher morbidity and mortality and at a younger age.
Citations
Citations to this article as recorded by
Global, regional, and national burdens of alcohol-related cirrhosis among women from 1992 to 2021 and its predictions Zhou Zhang, Chun-mei Xu, Wei Chen, Kai-tao Yao, Ting Sun, Jing-hui Wang Scientific Reports.2025;[Epub] CrossRef
Machine learning-based nomogram for mortality risk stratification in cirrhotic patients with sepsis: a single-center predictive model Xing-Cheng Zhang, Bo-Wen Li, Xi-Qun Lei, Nan-Bing Shan, Jun-Ping Wei, Zhong-Hua Lu, Yun Sun Frontiers in Medicine.2025;[Epub] CrossRef
Insights into the Multifaceted Roles and Pleiotropic Functions of ALDH1L2 with Implications in Gastrointestinal Diseases and Cancer Partha Pratim Das, Subhash Medhi, Sangit Dutta, Anjan Jyoti Talukdar, Samudrala Gourinath Current Genetic Medicine Reports.2025;[Epub] CrossRef
Noninvasive Prognostic Scoring Systems in Male Alcoholic Liver Cirrhosis: A Retrospective Study Cuiqin Li, Xia Peng, Yu Yang Hepatitis Monthly.2025;[Epub] CrossRef
Burden of caregiving of alcohol related liver disease patients: a possible role of training and caregiver groups frequency. Proposal of a method, preliminary results Patrizia BALBINOT, Rinaldo PELLICANO, Gianni TESTINO Minerva Gastroenterology.2024;[Epub] CrossRef
Etiological Spectrum of Cirrhosis in India: A Systematic Review and Meta-analysis Shekhar Swaroop, Manas Vaishnav, Umang Arora, Sagnik Biswas, Arnav Aggarwal, Soumya Sarkar, Puneet Khanna, Anshuman Elhence, Ramesh Kumar, Amit Goel, Shalimar Journal of Clinical and Experimental Hepatology.2024; 14(2): 101291. CrossRef
Alcohol consumption, alcohol use disorder and organ transplantation Gianni TESTINO, Rinaldo PELLICANO, Fabio CAPUTO Minerva Gastroenterology.2024;[Epub] CrossRef
Outcomes and Recurrence Rate of Esophageal Varices after Endoscopic Treatment in Patients with Alcoholic Cirrhosis and Viral Cirrhosis Yoshihiro Furuichi, Ryohei Nishiguchi, Takeshi Shimakawa, Tomoyuki Fujiwara, Koichiro Sato, Hiroyuki Kato Journal of Nippon Medical School.2024; 91(2): 180. CrossRef
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance Takao Miwa, Yuki Utakata, Tatsunori Hanai, Masashi Aiba, Shinji Unome, Kenji Imai, Koji Takai, Makoto Shiraki, Naoki Katsumura, Masahito Shimizu Journal of Gastroenterology.2024; 59(9): 849. CrossRef
Incidence and risk factors of acute kidney injury in cirrhosis: a systematic review and meta-analysis of 5,202,232 outpatients, inpatients, and ICU-admitted patients Vasileios Lekakis, Aikaterini Gkoufa, John Vlachogiannakos, George V. Papatheodoridis, Evangelos Cholongitas Expert Review of Gastroenterology & Hepatology.2024; 18(7): 377. CrossRef
Association of Alcohol Consumption With Liver Cancer and All-Cause Mortality in Chronic Hepatitis B Patients Without Cirrhosis BYUNGYOON Yun, JUYEON OH, SANG HOON AHN, JIN-HA Yoon, BEOM KYUNG Kim Clinical Gastroenterology and Hepatology.2023; 21(12): 3191. CrossRef
Current and future treatment for alcoholic‐related liver diseases Eileen L. Yoon, Won Kim Journal of Gastroenterology and Hepatology.2023; 38(8): 1218. CrossRef
Excess mortality in elderly hip fracture patients: An Indian experience Jaiben George, Vijay Sharma, Kamran Farooque, Vivek Trikha, Samarth Mittal, Rajesh Malhotra Chinese Journal of Traumatology.2023; 26(6): 363. CrossRef
Overview of Complications in Cirrhosis Madhumita Premkumar, Anil C. Anand Journal of Clinical and Experimental Hepatology.2022; 12(4): 1150. CrossRef
Liver cirrhosis Garima Singh, Suman Bala, Sonal Katoch, Lakhvinder Kaur, Anil Kumar, Abhishek Kumar, Alok Bharadwaj, Ardhariksa Zukhruf Kurniullah International journal of health sciences.2022; : 5547. CrossRef
Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease Ji Ye Hyun, Seul Ki Kim, Sang Jun Yoon, Su Been Lee, Jin-Ju Jeong, Haripriya Gupta, Satya Priya Sharma, Ki Kwong Oh, Sung-Min Won, Goo Hyun Kwon, Min Gi Cha, Dong Joon Kim, Raja Ganesan, Ki Tae Suk International Journal of Molecular Sciences.2022; 23(15): 8749. CrossRef
Predictive Factors for the Prognosis of Alcoholic Liver Cirrhosis Anca Trifan, Horia Minea, Adrian Rotaru, Carol Stanciu, Remus Stafie, Ermina Stratina, Sebastian Zenovia, Robert Nastasa, Ana-Maria Singeap, Irina Girleanu, Cristina Muzica, Laura Huiban, Tudor Cuciureanu, Stefan Chiriac, Catalin Sfarti, Camelia Cojocariu Medicina.2022; 58(12): 1859. CrossRef
Alcohol-related cirrhosis: The most challenging etiology of cirrhosis is more burdensome than ever Marta Tonon, Salvatore Piano Clinical and Molecular Hepatology.2021; 27(1): 94. CrossRef
The current standard of care for severe alcoholic hepatitis (SAH) has several limitations in that only up to one-third of patients are eligible for steroid therapy. Additionally, steroids have their own issues: a portion of patients do not respond, while there is doubtful long-term benefit in those who do and a large proportion are ineligible to receive steroids entirely and hence have no definitive options for treatment. As such, there is a large gap between the problem and the available solutions. Alcohol causes dysbiosis and also disrupts gut barrier function, consequently promoting the translocation of microbial lipopolysaccharide into the portal circulation and liver. Therefore, probiotics, prebiotics, antibiotics, or transplantation of gut microbiota are likely to attenuate the dysbiosis-related liver insult. Fecal microbiota transplantation (FMT) is expected to have a role in managing alcoholic liver disease in general and SAH in particular by correcting dysbiosis, the primary insult. Results from mouse studies have suggested beyond doubt that alcohol-related liver injury is transferrable and also treatable by adopting FMT from suitable donors. Initial human trials from our center have affirmed benefits in human subjects with SAH as well, with both improvements in disease severity and as well as the rate of survival. Further studies addressing the head-to-head comparison of steroids and FMT are ongoing. Available preliminary data are promising and FMT and/or gut microbial modulation might become the standard of care in the near future for managing alcohol-related liver diseases, especially alcoholic hepatitis, with greater applicability, improved acceptability, and minimal side effects.
Citations
Citations to this article as recorded by
Alcohol-Related Liver Disease Haripriya Maddur, Steven Flamm Clinics in Liver Disease.2026; 30(1): 45. CrossRef
Puerarin ameliorates alcoholic liver disease by regulating intestinal flora and MAPK/Nrf2 signalling pathways Zicheng Wang, Yingying Yu, Wanjun Shao, Yuhao Zhao, Zhe Li, Jiaming Han, Jingyu Wen, Yongchun Meng, Ying Lin, Shaoping Wang Ecotoxicology and Environmental Safety.2026; 309: 119699. CrossRef
Gut Microbiome and Bile Acid Metabolism in Liver Disease: Mechanisms, Clinical Implications, and Therapeutic Opportunities Huiping Zhou, Yi Huang, Chen Chen, Meiyi Song, Phillip.B. Hylemon Pharmacological Reviews.2026; : 100120. CrossRef
Prospective study on time-to-tertiary care in alcohol-associated hepatitis: space–time coordinates as prognostic tool and therapeutic target Ľubomír Skladaný, Daniela Žilinčanová, Natália Kubánek, Svetlana Adamcová Selčanová, Daniel Havaj, Lukáš Laffers, Michal Žilinčan, Alvi H Islam, Juan Pablo Arab, Tomáš Koller Alcohol and Alcoholism.2025;[Epub] CrossRef
The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma Sang Jun Yoon, Seul Ki Han, Tae Suk Kim, Ki Tae Suk, Dae Hee Choi, Young Don Kim, Moon Young Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim Critical Reviews in Microbiology.2025; 51(6): 1315. CrossRef
Prolonged Intestinal Ethanol Absorption and Oxidative Stress: Revisiting the Gut–Liver Axis in Alcohol-Associated Disease Beom Sun Chung, Keungmo Yang, Chihyun Park, Tom Ryu International Journal of Molecular Sciences.2025; 26(12): 5442. CrossRef
Correction of vaginal microbiocenosis in bacterial vaginosis. Promising areas G.O. Grechkanev, I.O. Strelets, N.N. Nikishov, E.V. Sinitsina, A.N. Nikishova Russian Bulletin of Obstetrician-Gynecologist.2025; 25(4): 44. CrossRef
Alcohol-Induced Oxidative Stress and Gut–Liver–Brain Crosstalk: Expanding the Paradigm from ALD to MetALD Jeong-Yoon Lee, Young-Min Jee, Keungmo Yang, Tom Ryu Antioxidants.2025; 14(10): 1196. CrossRef
A systematic review and meta-analysis on the efficacy of fecal microbiome transplantation in patients with severe alcohol-associated hepatitis Evance Pakuwal, Jin Lin Tan, Richard J. Woodman, Amanda J. Page, Andrea M. Stringer, Mohamed Asif Chinnaratha European Journal of Gastroenterology & Hepatology.2025; 37(11): 1260. CrossRef
Fecal Microbiota Transplant in Alcoholic Liver Disease: A Review of Current Literature Alexander Grieme, Yizhong Wu, Kalee Moore, Manuel Garza, Eric R. Smith, Erica Yatsynovich, Thomas J. Egeland, Rajesh Shah Therapeutics.2025; 3(1): 2. CrossRef
Intestinal microbiome-targeted therapies improve liver function in alcohol-related liver disease by restoring bifidobacteria: a systematic review and meta-analysis Xin Chi, Xiu Sun, Danying Cheng, Shunai Liu, Calvin Q. Pan, Huichun Xing Frontiers in Pharmacology.2024;[Epub] CrossRef
Chronic Liver Disease and Promising Therapeutic Strategy: A Concise Review Han Yu, Zhijun Wang, Gang Zhao Pharmacognosy Magazine.2024; 20(4): 1031. CrossRef
Inflammatory liver diseases and susceptibility to sepsis Hong Lu Clinical Science.2024; 138(7): 435. CrossRef
Fecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol Arantza Lamas-Paz, Mariana Mesquita, Marcos Garcia-Lacarte, Olga Estévez-Vázquez, Raquel Benedé-Ubieto, Alejandro H. Gutierrez, Hanghang Wu, Hector Leal Lasalle, Javier Vaquero, Rafael Bañares, Eduardo Martínez-Naves, Sergio Roa, Yulia A. Nevzorova, Gonza Frontiers in Nutrition.2024;[Epub] CrossRef
Digestive dynamics: Unveiling interplay between the gut microbiota and the liver in macronutrient metabolism and hepatic metabolic health Mrunmayee R. Kandalgaonkar, Virender Kumar, Matam Vijay‐Kumar Physiological Reports.2024;[Epub] CrossRef
Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon Linda Galasso, Lucia Cerrito, Valeria Maccauro, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco International Journal of Molecular Sciences.2024; 25(13): 7191. CrossRef
Faecal microbiota transplantation associated adverse events Rafal Patryn, Natalia Kazmierczak-Wojtas, Lucyna Bulas, Olga Boretska, Monika Szkultecka-Debek, Mariola Drozd, Tomasz Blicharski Current Issues in Pharmacy and Medical Sciences.2024; 37(3): 171. CrossRef
Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives Mengyao Yan, Shuli Man, Long Ma, Lanping Guo, Luqi Huang, Wenyuan Gao Clinical and Molecular Hepatology.2024; 30(4): 620. CrossRef
3PM-guided innovation in treatments of severe alcohol-associated hepatitis utilizing fecal microbiota transplantation Lubomir Skladany, Natalia Kubanek, Svetlana Adamcova Selcanova, Daniela Zilincanova, Daniel Havaj, Karolina Sulejova, Katarina Soltys, Lucia Messingerova, Michal Lichvar, Lukas Laffers, Michal Zilincan, Eva Honsova, Peter Liptak, Peter Banovcin, Jan Bures EPMA Journal.2024; 15(4): 677. CrossRef
Mapping the relationship between alcohol use disorder and gut microbiota: a 20-year bibliometric study Ao Xiang, Yonglong Chang, Li Shi, Xuhui Zhou Frontiers in Microbiology.2024;[Epub] CrossRef
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease Hui Gao, Yanchao Jiang, Ge Zeng, Nazmul Huda, Themis Thoudam, Zhihong Yang, Suthat Liangpunsakul, Jing Ma eGastroenterology.2024; 2(4): e100104. CrossRef
Conventional type 1 dendritic cells protect against gut barrier disruption via maintaining Akkermansia muciniphila in alcoholic steatohepatitis Liuyi Hao, Wei Zhong, Jongmin Woo, Xiaoyuan Wei, Hao Ma, Haibo Dong, Wei Guo, Xinguo Sun, Ruichao Yue, Jiangchao Zhao, Qibin Zhang, Zhanxiang Zhou Hepatology.2023; 78(3): 896. CrossRef
TRPV6 deficiency attenuates stress and corticosterone-mediated exacerbation of alcohol-induced gut barrier dysfunction and systemic inflammation Avtar S. Meena, Pradeep K. Shukla, Rupa Rao, Cherie Canelas, Joseph F. Pierre, RadhaKrishna Rao Frontiers in Immunology.2023;[Epub] CrossRef
The Role of Microbiota in Liver Transplantation and Liver Transplantation-Related Biliary Complications Ulrich Wirth, Tianxiao Jiang, Josefine Schardey, Katharina Kratz, Mingming Li, Malte Schirren, Florian Kühn, Alexandr Bazhin, Jens Werner, Markus Guba, Christian Schulz, Joachim Andrassy International Journal of Molecular Sciences.2023; 24(5): 4841. CrossRef
Gut Microbiota: A Future Clinical Magic Bullet to Manifest Pathogenic Disease in the Current Future Pooja Rani Mina Journal of Pure and Applied Microbiology.2023; 17(1): 51. CrossRef
The human microbiome and gut–liver axis in people living with HIV Maria J. Duarte, Phyllis C. Tien, Ma Somsouk, Jennifer C. Price Current HIV/AIDS Reports.2023; 20(3): 170. CrossRef
Exploring the diversity of blood microbiome during liver diseases: Unveiling Novel diagnostic and therapeutic Avenues Dinakaran Vasudevan, Arulraj Ramakrishnan, Ganesan Velmurugan Heliyon.2023; 9(11): e21662. CrossRef
Fecal Microbiota Transplantation in Liver Cirrhosis Adrian Boicean, Victoria Birlutiu, Cristian Ichim, Olga Brusnic, Danusia Maria Onișor Biomedicines.2023; 11(11): 2930. CrossRef
Advances in the management of alcohol-associated liver disease Ahmad Anouti, Thomas A Kerr, Mack C Mitchell, Thomas G Cotter Gastroenterology Report.2023;[Epub] CrossRef
Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation Sergii Tkach, Andrii Dorofeyev, Iurii Kuzenko, Nadiya Boyko, Tetyana Falalyeyeva, Luigi Boccuto, Emidio Scarpellini, Nazarii Kobyliak, Ludovico Abenavoli Medicina.2022; 58(1): 84. CrossRef
Intestinal Microbiota Contributes to the Improvement of Alcoholic Hepatitis in Mice Treated With Schisandra chinensis Extract Jun-Yan Xiang, Yan-Yu Chi, Jin-Xin Han, Xinyu Shi, Yong Cai, Hongyu Xiang, Qiuhong Xie Frontiers in Nutrition.2022;[Epub] CrossRef
Recent insights into the hepatoprotective effects of lactic acid bacteria in alcoholic liver disease Xiaoqian Sun, Jingjing Shi, Lingyu Kong, Qiyuan Shen, Xiaoqun Zeng, Zhen Wu, Yuxing Guo, Daodong Pan Trends in Food Science & Technology.2022; 125: 91. CrossRef
Predictive and Prognostic Roles of Gut Microbial Variation in Liver Transplant Hon Jen Wong, Wen Hui Lim, Cheng Han Ng, Darren Jun Hao Tan, Glenn K. Bonney, Alfred W. C. Kow, Daniel Q. Huang, Mohammad Shadab Siddiqui, Mazen Noureddin, Nicholas Syn, Mark D. Muthiah Frontiers in Medicine.2022;[Epub] CrossRef
Principles of diagnosis and treatment of alcohol-induced liver fibrosis D. V. Garbuzenko Meditsinskiy sovet = Medical Council.2022; (7): 104. CrossRef
TRPV6 channel mediates alcohol-induced gut barrier dysfunction and systemic response Avtar S. Meena, Pradeep K. Shukla, Briar Bell, Francesco Giorgianni, Rebeca Caires, Carlos Fernández-Peña, Sarka Beranova, Eitaro Aihara, Marshall H. Montrose, Mehdi Chaib, Liza Makowski, Indira Neeli, Marko Z. Radic, Valeria Vásquez, Jonathan H. Jaggar, Cell Reports.2022; 39(11): 110937. CrossRef
Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances Hao Qin, Baowen Yuan, Wei Huang, Yan Wang Frontiers in Oncology.2022;[Epub] CrossRef
Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives Yoonji Ha, Inju Jeong, Tae Hyun Kim Biomedicines.2022; 10(10): 2530. CrossRef
Pathophysiological Prerequisites and Therapeutic Potential of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis D. V. Garbuzenko The Russian Archives of Internal Medicine.2022; 12(5): 352. CrossRef
Finding a Balance in the Vaginal Microbiome: How Do We Treat and Prevent the Occurrence of Bacterial Vaginosis? Rebecca Jane Joseph, Hooi-Leng Ser, Yi-He Kuai, Loh Teng-Hern Tan, Valliammai Jayanthi Thirunavuk Arasoo, Vengadesh Letchumanan, Lijing Wang, Priyia Pusparajah, Bey-Hing Goh, Nurul-Syakima Ab Mutalib, Kok-Gan Chan, Learn-Han Lee Antibiotics.2021; 10(6): 719. CrossRef
From intestinal dysbiosis to alcohol-associated liver disease Beatriz Garcia Mendes, Bernd Schnabl Clinical and Molecular Hepatology.2020; 26(4): 595. CrossRef
Alcohol and hepatocarcinogenesis Makiko Taniai Clinical and Molecular Hepatology.2020; 26(4): 736. CrossRef
Background/Aims The aim of this study was to study the efficacy and safety of zolpidem for sleep disturbances in patients with cirrhosis.
Methods Fifty-two Child-Turcotte-Pugh (CTP) class A or B cirrhotics with Pittsburgh Sleep Quality Index >5 were randomized to either zolpidem 5 mg daily (n=26) or placebo (n=26) for 4 weeks.
Result s: The therapy of 4 weeks was completed by 23 patients receiving zolpidem (3 stopped treatment due to excessive daytime drowsiness) and 24 receiving placebo (2 refused to continue the study). In the zolpidem group, after 4 weeks of therapy, there was significant increase in total sleep time (TST) and sleep efficiency compared to baseline and improvement in polysomnographic parameters of sleep initiation and maintenance (i.e., decrease in sleep latency time, decrease in wake time, and decreases in number of arousals and periodic limbs movements per hour of sleep), without any significant change in sleep architecture.
Conclusions Four weeks of 5 mg daily zolpidem in CTP class A or B cirrhosis patients with insomnia led to significant increases in TST and sleep efficiency and improvement in polysomnographic parameters of sleep initiation and maintenance without any significant change in sleep architecture.
Citations
Citations to this article as recorded by
Comprehensive Insight into Analytical Strategies for the Determination of Zolpidem and Its Metabolites in Different Matrices Hemn A.H Barzani, Rebaz Anwar Omer, Nergz Bayiz Abdulrahman, Zanco Hassan Jawhar, Seerwan Hamadameen Sulaiman, Ali Abdulhameed Mohammedsaeed Critical Reviews in Analytical Chemistry.2026; : 1. CrossRef
Auricular Acupressure for Insomnia in Patients with Decompensated Hepatitis B-Related Liver Cirrhosis: A Clinical Observation Xiaotong Du, Jingfang Hu, Qi Feng, Shuang Liang, Shuhui Zhao, Feifei Liu Acupuncture & Electro-Therapeutics Research: International Journal of Integrated Medicine.2026;[Epub] CrossRef
Exploring the Impact of Obstructive Sleep Apnea on Cirrhosis Zahra Dossaji, Rajan Amin, Vignan Manne Journal of Clinical Gastroenterology.2025; 59(6): 504. CrossRef
Liver Cirrhosis and Sleep Disorders Jiawen Feng, Wei Zhang, Qing Ye Portal Hypertension & Cirrhosis.2025; 4(4): 265. CrossRef
The Beauty Sleep to Keep a Healthy Liver Mariana Verdelho Machado International Journal of Molecular Sciences.2025; 26(23): 11322. CrossRef
Drug-facilitated sexual assault followed by femicidal chloroform poisoning and suffocation: A case-report of criminal responsibility Jessika Camatti, Ivan Galliani, Antonello Cirnelli, Rossana Cecchi Legal Medicine.2024; 66: 102356. CrossRef
Sleep disturbances in chronic liver disease Bradley Busebee, Kymberly D. Watt, Kara Dupuy-McCauley, Hilary DuBrock Liver Transplantation.2024; 30(10): 1058. CrossRef
Management of fatigue and sleep disorders in patients with chronic liver disease Sebastian Niezen, Alan Noll, Judith Bamporiki, Shari S. Rogal Clinical Liver Disease.2024;[Epub] CrossRef
Subclinical brain manifestations of repeated mild traumatic brain injury are changed by chronic exposure to sleep loss, caffeine, and sleep aids Carol A. Everson, Aniko Szabo, Cade Plyer, Thomas A. Hammeke, Brian D. Stemper, Matthew D. Budde Experimental Neurology.2024; 381: 114928. CrossRef
Sleep disturbance in patients with cirrhosis and transjugular intrahepatic portosystemic shunt Ming Zhao, Yuling Yan, Xiaoze Wang, Bangxi Liu, Xuefeng Luo BMC Gastroenterology.2024;[Epub] CrossRef
Outpatient management after hospitalisation for acute decompensation of cirrhosis: A practical guide Adonis A Protopapas, Alexandra Tsankof, Ioanna Papagiouvanni, Georgia Kaiafa, Lemonia Skoura, Christos Savopoulos, Ioannis Goulis World Journal of Hepatology.2024; 16(12): 1377. CrossRef
Associations of Multiple Serum Trace Elements with Abnormal Sleep Duration Patterns in Hospitalized Patient with Cirrhosis Yangyang Hui, Gaoyue Guo, Lihong Mao, Yifan Li, Mingyu Sun, Xiaoyu Wang, Wanting Yang, Xiaofei Fan, Kui Jiang, Binxin Cui, Chao Sun Biological Trace Element Research.2023; 201(7): 3202. CrossRef
Targets and study design for symptom-focused trials aimed at patients with cirrhosis: An expert consensus Arpan A. Patel, Elliot B. Tapper, Fasiha Kanwal, Christopher D. Woodrell, Lissi Hansen, Jennifer C. Lai, Shari Rogal, Cara McDermott, Mina Rakoski, Nneka N. Ufere Hepatology Communications.2023;[Epub] CrossRef
Prevalence, Severity, and Predictors of Insomnia in Advanced Colorectal Cancer Aaron K. Wong, Dorothy Wang, David Marco, Brian Le, Jennifer Philip Journal of Pain and Symptom Management.2023; 66(3): e335. CrossRef
Association between serum trace elements and sleep disturbance in patients with decompensated cirrhosis Ziyue Zhang, Yangyang Hui, Wanting Yang, Gaoyue Guo, Binxin Cui, Chaoqun Li, Xiaoyu Wang, Xiaofei Fan, Chao Sun Therapeutic Advances in Chronic Disease.2023;[Epub] CrossRef
Severe chronic abuse of zolpidem for over 10 years: a case report and review of similar cases Reza Moshfeghinia, Kimia Jazi, Shabnam Kabaranzadghadim, Mahdi Malekpour, Bahare Oji Frontiers in Psychiatry.2023;[Epub] CrossRef
Sleep disturbances in patients with cirrhosis: Pursuing just right Yangyang Hui, Xin Chen, Chao Sun Portal Hypertension & Cirrhosis.2023; 2(4): 181. CrossRef
Efficacy, Safety, and Drug–Drug Interactions for Insomnia Therapy in COVID-19 Patients Billy Dwi Saputra, Jutti Levita, Resmi Mustarichie Journal of Multidisciplinary Healthcare.2022; Volume 15: 137. CrossRef
Review article: current and emerging therapies for the management of cirrhosis and its complications Elliot B. Tapper, Nneka N. Ufere, Daniel Q. Huang, Rohit Loomba Alimentary Pharmacology & Therapeutics.2022; 55(9): 1099. CrossRef
Symptom Management in Patients with Cirrhosis: a Practical Guide Alyson Kaplan, Russell Rosenblatt Current Treatment Options in Gastroenterology.2022; 20(2): 144. CrossRef
AASLD Practice Guidance: Palliative care and symptom‐based management in decompensated cirrhosis Shari S. Rogal, Lissi Hansen, Arpan Patel, Nneka N. Ufere, Manisha Verma, Christopher D. Woodrell, Fasiha Kanwal Hepatology.2022; 76(3): 819. CrossRef
Seeking bridge symptoms of anxiety, depression, and sleep disturbance among the elderly during the lockdown of the COVID-19 pandemic—A network approach Liang Zhang, Yanqiang Tao, Wenxin Hou, Haiqun Niu, Zijuan Ma, Zeqing Zheng, Shujian Wang, Shuang Zhang, Yichao Lv, Qiubai Li, Xiangping Liu Frontiers in Psychiatry.2022;[Epub] CrossRef
Case Report: High doses of Zolpidem and QT interval lengthening: Is there a relationship? A case series Simone Campagnari, Lorenzo Zamboni, Francesca Fusina, Rebecca Casari, Fabio Lugoboni Frontiers in Psychiatry.2022;[Epub] CrossRef
Comprehensive Overview of Sleep Disorders in Patients with Chronic Liver Disease Oana-Mihaela Plotogea, Madalina Ilie, Simona Bungau, Alexandru Laurentiu Chiotoroiu, Ana Maria Alexandra Stanescu, Camelia Cristina Diaconu Brain Sciences.2021; 11(2): 142. CrossRef
Music intervention for sleep quality in critically ill and surgical patients: a meta-analysis Ellaha Kakar, Esmée Venema, Johannes Jeekel, Markus Klimek, Mathieu van der Jagt BMJ Open.2021; 11(5): e042510. CrossRef
Relationship Between Sleep–Wake Disturbance and Risk of Malnutrition in Hospitalized Patients With Cirrhosis Yangyang Hui, Xiaoyu Wang, Zihan Yu, Hongjuan Feng, Chaoqun Li, Lihong Mao, Xiaofei Fan, Lin Lin, Binxin Cui, Xin Chen, Longhao Sun, Bangmao Wang, Chao Sun Frontiers in Nutrition.2021;[Epub] CrossRef
Sleep and liver disease: a bidirectional relationship Thomas Marjot, David W Ray, Felicity R Williams, Jeremy W Tomlinson, Matthew J Armstrong The Lancet Gastroenterology & Hepatology.2021; 6(10): 850. CrossRef
Association between sleep disturbance and multidimensional frailty assessed by Frailty Index in hospitalized cirrhosis Yangyang Hui, Lin Xu, Xiaoyu Wang, Hongjuan Feng, Zihan Yu, Chaoqun Li, Lihong Mao, Xiaofei Fan, Bangmao Wang, Xin Chen, Chao Sun European Journal of Gastroenterology & Hepatology.2021; 33(1S): e727. CrossRef
Impact of Sleep Disorder as a Risk Factor for Dementia in Men and Women Hye Jin Jee, Wonseok Shin, Ho Joong Jung, Baekgyu Kim, Bo Kyung Lee, Yi-Sook Jung Biomolecules & Therapeutics.2020; 28(1): 58. CrossRef
First
Prev
